Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

OXC 201

Next Previous
Drug Profile

OXC 201

Alternative Names: OGG1 inhibitor – Oxcia; OXC-201; TH5487

Latest Information Update: 14 Oct 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Oxcia
  • Class Anti-inflammatories; Antiallergics; Antifibrotics; Antivirals; Small molecules
  • Mechanism of Action Oxoguanine glycosylase 1 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Idiopathic pulmonary fibrosis
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Allergic asthma; Idiopathic pulmonary fibrosis; Viral infections

Most Recent Events

  • 14 Oct 2025 OXC 201 receives Orphan Drug status for Idiopathic pulmonary fibrosis, prior to October 2025 (Oxcia pipeline, October 2025)
  • 09 Sep 2025 Preclinical trials in Viral infections in Sweden (PO) prior to September 2025
  • 09 Sep 2025 Pharmacodynamics data from a preclinical trial in Viral infections released by Oxecia (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top